Antibody Subclass and Glycosylation Shift Following Effective TB Treatment
<jats:p>With an estimated 25% of the global population infected with <jats:italic>Mycobacterium tuberculosis</jats:italic> (<jats:italic>Mtb</jats:italic>), tuberculosis (TB) remains a leading cause of death by infectious diseases. Humoral immunity following TB treatmen...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media SA
2021
|
Online Access: | https://hdl.handle.net/1721.1/136134 |